Reuters (10/28, Crist) reports that research indicates “women are becoming more aware of the term ‘breast density,’ but they aren’t as familiar with its relation to breast cancer risk or mammograms.” The study found that “African American and Ashkenazi Jewish women, who may be at a higher risk for breast cancer, seemed to be less knowledgeable about breast density.” The findings were published online in the Journal of the American College of Radiology.
Diagnostic Imaging (10/28) reported that research indicated “MRI before surgery in women whose cancer was detected by ultrasound found additional cancers.” The findings were published in Radiology.
Medscape (10/27, Tucker) reports on a study from the National Cancer Database presented at the American College of Surgeons Clinical Congress that examined follow-up preventative care in patients who undergo surgery for breast cancer. While the guidelines from the “American Cancer Society and the National Comprehensive Cancer Network recommend mammography 6 to 12 months after completion of radiation therapy for breast cancer and annual mammography thereafter,” the study found “that only two thirds of women diagnosed with stage II or III disease receive breast imaging in the first follow-up year after surgery, and nearly two thirds are not receiving annual imaging for the subsequent 4 years.”
Aunt Minnie (10/26) reports, “New York City Public Advocate Letitia James has called on New York City and the state of New York to expand access to digital breast tomosynthesis (DBT).” Earlier this week “in a...press conference, James requested that NYC Health + Hospitals invest in DBT technology and for the state to add DBT to its Medicaid benefits package.” James “noted that while DBT technology is widely available in private hospitals in New York City, it’s only available at one hospital in the NYC Health + Hospitals network.”
DOT Med News (10/26, Mitchell) reports that a “study of a 2014 law that requires insurance companies to pay for supplemental ultrasound and/or MR screening if a woman has dense breasts diagnosed reveals that it has resulted in better patient care and outcomes.” Dr. Linda Sanders, lead author of the study, told HCB News, “The number of supplemental screening ultrasound and MR examinations increased after [The New Jersey Breast Density Law (NJBDL)] implementation.” The “‘review affirmed the high efficacy of screening MR compared with other modalities,’ she said, which the team credits to MR’s unique ability to detect lesions in soft tissue.” The findings were published in the Journal of the American College of Radiology.